Episode Synopsis "Refining Radiation Therapy for Lung Cancer, Part 4: Defining a Role for SBRT (audio)"

Dr. Vivek Mehta, Radiation Oncologist at Swedish Cancer Institute in Seattle, WA, covers the benefits and limitations of stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC).

Listen "Refining Radiation Therapy for Lung Cancer, Part 4: Defining a Role for SBRT (audio)"

More episodes of the podcast GRACEcast Radiation Oncology Audio

• Refining Radiation Therapy for Lung Cancer, Part 6: Moving Radiation Developments into Metastatic Lung Cancer (audio)
• Refining Radiation Therapy for Lung Cancer, Part 5: New Techniques (audio)
• Refining Radiation Therapy for Lung Cancer, Part 4: Defining a Role for SBRT (audio)
• Refining Radiation Therapy for Lung Cancer, Part 3: Recent Successes and Open Questions (audio)
• Refining Radiation Therapy for Lung Cancer, Part 2: The Rationale for Stereotactic Body Radiation Therapy, by Dr. Vivek Mehta (audio)
• Refining Radiation Therapy for Lung Cancer, Part 1: A Historical Perspective, by Dr. Vivek Mehta (audio)
• GRACEcast Feeds Moving (audio)
• Interview with Raditation Oncologist Vivek Mehta: Radiation from Stage I to Stage IV NSCLC (audio)
• Vivek Mehta Interview (audio)